MOLECULAR GENETICS AND METABOLISM

Scope & Guideline

Transforming Knowledge in Biochemistry and Genetics

Introduction

Welcome to the MOLECULAR GENETICS AND METABOLISM information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of MOLECULAR GENETICS AND METABOLISM, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1096-7192
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1998 to 2024
AbbreviationMOL GENET METAB / Mol. Genet. Metab.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal "Molecular Genetics and Metabolism" primarily focuses on advancing the understanding of genetic and metabolic disorders through innovative research methodologies. It serves as a platform for disseminating findings related to the molecular and biochemical bases of inherited metabolic diseases, genetic variations, and treatment approaches.
  1. Genetic and Molecular Basis of Inherited Disorders:
    Research exploring the genetic mutations and molecular mechanisms underlying various inherited metabolic disorders, providing insights into their pathophysiology.
  2. Clinical Applications and Treatment Strategies:
    Studies that evaluate the efficacy of current treatments, including enzyme replacement therapies and novel pharmacological approaches, aimed at improving patient outcomes.
  3. Biochemical and Metabolic Profiling:
    Investigations into the metabolic profiles associated with specific genetic disorders to identify biomarkers for diagnosis and treatment monitoring.
  4. Patient-Centric Research:
    Research that emphasizes patient experiences, quality of life, and caregiver perspectives, contributing to a holistic understanding of the impact of metabolic diseases.
  5. Innovative Therapeutic Approaches:
    Development and evaluation of innovative therapies, including gene therapy, substrate reduction therapy, and pharmacological chaperones, to address metabolic disorders.
Recent publications indicate a trend towards more innovative and patient-focused research themes within the field of molecular genetics and metabolism. These emerging areas are vital for advancing understanding and treatment of genetic disorders.
  1. Gene Therapy and Genome Editing:
    An increasing number of studies focus on gene therapy techniques, including CRISPR and AAV-mediated gene delivery, highlighting their potential in treating metabolic disorders.
  2. Patient-Reported Outcomes and Quality of Life:
    Research emphasizing the importance of patient-reported outcomes and the psychosocial impact of metabolic diseases is gaining prominence, reflecting a shift towards patient-centered care.
  3. Multi-Omics Approaches:
    There is a growing trend towards integrating genomics, proteomics, and metabolomics to provide a more comprehensive understanding of metabolic disorders and their treatment.
  4. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated research into telemedicine and remote monitoring strategies, showcasing their effectiveness in managing patient care during public health crises.
  5. Personalized Medicine:
    Emerging themes in personalized medicine highlight the need for tailored treatment approaches based on individual genetic profiles, enhancing therapeutic efficacy.

Declining or Waning

While the journal remains focused on genetic and metabolic research, certain themes have shown a decline in prominence over recent years, reflecting shifts in research priorities and advancements in technology.
  1. Traditional Diagnostic Methods:
    There has been a noticeable decrease in publications focused on conventional diagnostic methods, as newer genomic and metabolomic techniques gain traction.
  2. General Population Studies:
    Research involving broad population studies without a specific focus on genetic or metabolic disorders has diminished, as more targeted studies are preferred.
  3. Basic Biochemistry without Clinical Relevance:
    Papers that explore basic biochemical pathways without direct clinical applications or implications for patient care are becoming less frequent.
  4. Animal Models with Limited Translational Relevance:
    Research utilizing animal models that do not effectively translate to human conditions or lack clear therapeutic implications is less commonly published.

Similar Journals

GENETICS AND MOLECULAR BIOLOGY

Advancing the frontiers of genetics and molecular biology.
Publisher: SOC BRASIL GENETICAISSN: 1415-4757Frequency: 4 issues/year

GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Driving innovation in diabetes and metabolic research.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1849Frequency: 12 issues/year

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Pioneering Discoveries in Pediatric Metabolic Health
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

CLINICAL ENDOCRINOLOGY

Innovating diagnostics and treatments for endocrine disorders.
Publisher: WILEYISSN: 0300-0664Frequency: 12 issues/year

CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.

Archives of Endocrinology Metabolism

Bridging science and practice in metabolic disorders.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Bone Reports

Pioneering discoveries in bone and metabolic health.
Publisher: ELSEVIERISSN: 2352-1872Frequency: 2 issues/year

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.

Annals of Pediatric Endocrinology & Metabolism

Empowering researchers to transform pediatric health.
Publisher: KOREAN SOC PEDIATRIC ENDOCRINOLOGYISSN: 2287-1012Frequency: 4 issues/year

Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.

Frontiers in Endocrinology

Advancing Knowledge in Endocrinology and Metabolism
Publisher: FRONTIERS MEDIA SAISSN: 1664-2392Frequency: 1 issue/year

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

Genetics Research

Fostering Global Collaboration in Genetic Research
Publisher: HINDAWI LTDISSN: 0016-6723Frequency: 1 issue/year

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Hormones-International Journal of Endocrinology and Metabolism

Transforming Understanding in Endocrinology and Metabolism
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.